Infectious disease burden and vaccination needs among asylees versus refugees, District of Columbia

Clinical Infectious Diseases

Volumn 56, Issue 5, 2013, Pages 652-658

  Chai, Shua J ^a   Davies Cole, John ^b   Cookson, Susan T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b District of Columbia Department of Health   (United States)

Author keywords

asylees; infectious diseases; refugees; screening; vaccinations

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASYLUM SEEKER; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH CARE NEED; HEALTH STATUS INDICATOR; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION; INTESTINE PARASITE; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MISCELLANEOUS NAMED GROUPS; NEEDS ASSESSMENT; NEWBORN; PARASITOSIS; POPULATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REFUGEE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROPREVALENCE; TUBERCULIN TEST; UNITED STATES; VACCINATION;

EID: 84873696008     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis927     Document Type: Article

References (40)

1. US Department of Homeland Security. 2010 yearbook of immigration statistics. Washington, DC: US Department of Homeland Security, Office of Immigration Statistics, 2011.
2. Lifson AR, Thai D, O'Fallon A, Mills WA, Hang K. Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota. Public Health Rep 2002; 117:69-77.
3. Husseini AS. Palestinian refugees in the West Bank and Gaza Strip: health =development. Med Confl Surviv 1996; 12:131-7.
4. Sutherland JE, Avant RF, Franz WB 3rd, Monzon CM, Stark NM. Indochinese refugee health assessment and treatment. J Fam Pract 1983; 16:61-7.
5. Centers for Disease Control and Prevention. Guidelines for the U.S. domestic medical examination for newly arriving refugees. Available at: http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/ domestic-guidelines.html. Accessed 5 October 2012.
6. Asgary RG, Metalios EE, Smith CL, Paccione GA. Evaluating asylum seekers/torture survivors in urban primary care: a collaborative approach at the Bronx Human Rights Clinic. Health Hum Rights 2006; 9:164-79.
7. Geltman PL, Dookeran NM, Battaglia T, Cochran J. Chronic disease and its risk factors among refugees and asylees in Massachusetts, 2001-2005. Prev Chron Dis 2010; 7:A51.
8. Keller AS, Ford D, Sachs E, et al. The impact of detention on the health of asylum seekers. J Ambul Care Manage 2003; 26:383-5.
9. Keller AS, Rosenfeld B, Trinh-Shevrin C, et al. Mental health of detained asylum seekers. Lancet 2003; 362:1721-3.
10. Piwowarczyk L. Asylum seekers seeking mental health services in the United States: clinical and legal implications. J Nerv Ment Dis 2007; 195:715-22.
11. Centers for Disease Control and Prevention. Latent tuberculosis infection: a guide for primary health care providers. Available at: http://www.cdc.gov/tb/publications/LTBI/diagnosis.htm. Accessed 5 October 2012.
12. Centers for Disease Control and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons report of the working group on tuberculosis among foreign-born persons. MMWR Recomm Rep 1998; 47:1-26.
13. American Academy of Pediatrics. Blastocystis hominis infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red book: 2009 report of the Committee on Infectious Diseases, 28th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2009:233-4.
14. Centers for Disease Control and Prevention. Domestic intestinal parasite guidelines. Available at: http://www.cdc.gov/immigrantrefugee health/guidelines/domestic/intestinal-parasites-domestic.html. Accessed 5 October 2012.
15. Centers for Disease Control and Prevention. Recommended adult immunization schedule-United States, October 2006-September 2007. MMWR Morb Mortal Wkly Rep 2006; 55:Q1-4.
16. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0-18 years-United States, 2007. MMWR Morb Mortal Wkly Rep 2006; 55:Q1-4.
17. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13-17 years-United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:1100-3.
18. Centers for Disease Control and Prevention. HIV prevalence estimates -United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57: 1073-6.
19. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months- United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 961-6.
20. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999-2000. Am J Respir Crit Care Med 2008; 177:348-55.
21. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010; 202:192-201.
22. World Health Organization. WHO vaccine preventable diseases monitoring system, 2007 global summary. Available at: http://www.who.int/vaccines/ globalsummary/immunization/countryprofileselect.cfm. Accessed 14 February 2008.
23. Euler GL, Lu P, Singleton JA. National Immunization Survey-adult. Atlanta, GA: Centers for Disease Control and Prevention, 2007.
24. American Thhoracic Society/Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161(4 Pt 2):S221-47.
25. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Longterm risk of tuberculosis among foreign-born persons in the United States. JAMA 1997; 278:304-7.
26. Cain KP, Benoit SR, Winston CA, Mac Kenzie WR. Tuberculosis among foreign-born persons in the United States. JAMA 2008; 300:405-12.
27. Centers for Disease Control and Prevention. Outbreak of multidrugresistant tuberculosis at a hospital-New York City, 1991. MMWR Morb Mortal Wkly Rep 1993; 42:427, 33-4.
28. Martin DC. Annual flow report. Refugees and asylees: 2010. In: Department of Homeland Security, ed. Washington, DC: Government Printing Office, 2011.
29. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293:2746-55.
30. Hariri S, McKenna MT. Epidemiology of human immunodeficiency virus in the United States. Clin Microbiol Rev 2007; 20:478-88.
31. Holtgrave DR. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both? Int J STD AIDS 2005; 16:777-81.
32. Centers for Disease Control and Prevention. Guidance for HIV for panel physicians and civil surgeons. Available at: http://www.cdc.gov/ immigrantrefugeehealth/exams/ti/hiv-guidance-panel-civil.html. Accessed 5 October 2012.
33. Salas SD, Heifetz R, Barrett-Connor E. Intestinal parasites in Central American immigrants in the United States. Arch Intern Med 1990; 150:1514-6.
34. Swanson SJ, Phares CR, Mamo B, Smith KE, Cetron MS, Stauffer WM. Albendazole therapy and enteric parasites in United Statesbound refugees. New Engl J Med 2012; 366:1498-507.
35. Centers for Disease Control and Prevention. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school-Cook County, Illinois, September 2006-January 2007. MMWR Morb Mortal Wkly Rep 2008; 57:796-9.
36. Measles: United States, January-May 20, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:666-8.
37. Chen SY, Anderson S, Kutty PK, et al. Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis 2011; 203:1517-25.
38. Persson A, Rombo L. Intestinal parasites in refugees and asylum seekers entering the Stockholm area, 1987-88: evaluation of routine stool screening. Scand J Infect Dis 1994; 26:199-207.
39. Reniers G, Araya T, Berhane Y, Davey G, Sanders EJ. Implications of the HIV testing protocol for refusal bias in seroprevalence surveys. BMC Public Health 2009; 9:163.
40. Reniers G, Eaton J. Refusal bias in HIV prevalence estimates from nationally representative seroprevalence surveys. AIDS 2009; 23:621-9.